The notion that MDM2 is a central player of serine metabolism was recently confirmed in liposarcomas (LPS), a sarcoma subtype characterized by a systematic amplification of MDM2. Interestingly, LPS, but not other sarcoma subtypes, display high levels of chromatin-bound MDM2. This evidence concerns the gene MDM2 and liposarcoma.